Let’s start up with the current stock price of Atossa Therapeutics Inc. (ATOS), which is $4.18 to be very precise. The Stock rose vividly during the last session to $4.68 after opening rate of $4.15 while the lowest price it went was recorded $3.83 before closing at $4.07.
Recently in News on June 11, 2021, Atossa Therapeutics Receives Approval from Swedish Regulators to Initiate Phase 2 Clinical Study of Oral Endoxifen to Reduce Mammographic Breast Density. Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in oncology and infectious disease with a current focus on breast cancer and COVID-19, announces that it has received approval from the Swedish Medical Product Agency (MPA) to initiate a Phase 2 clinical study of its oral Endoxifen for the reduction of mammographic breast density (MBD). MBD is an emerging public health issue affecting more than 10 million women in the United States and many more worldwide. Studies conducted by others have shown that MBD reduces the ability of mammograms to detect cancer (sensitivity) and increases the risk of developing breast cancer. Additional studies show a correlation between reducing MBD and a reduction in the incidence of breast cancer. You can read further details here
Atossa Therapeutics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $6.82 on 06/08/21, with the lowest value was $0.88 for the same time period, recorded on 01/06/21.
Atossa Therapeutics Inc. (ATOS) full year performance was 27.99%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Atossa Therapeutics Inc. shares are logging -38.78% during the 52-week period from high price, and 415.43% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.81 and $6.82.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 7586202 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Atossa Therapeutics Inc. (ATOS) recorded performance in the market was 328.42%, having the revenues showcasing 26.40% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 491.75M, as it employees total of 4 workers.
Market experts do have their say about Atossa Therapeutics Inc. (ATOS)
During the last month, 0 analysts gave the Atossa Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 2.76, with a change in the price was noted +2.74. In a similar fashion, Atossa Therapeutics Inc. posted a movement of +193.97% for the period of last 100 days, recording 19,902,746 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ATOS is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical breakdown of Atossa Therapeutics Inc. (ATOS)
Raw Stochastic average of Atossa Therapeutics Inc. in the period of last 50 days is set at 49.91%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 39.34%. In the last 20 days, the company’s Stochastic %K was 41.82% and its Stochastic %D was recorded 57.33%.
Bearing in mind the latest performance of Atossa Therapeutics Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 328.42%. Additionally, trading for the stock in the period of the last six months notably improved by 184.62%, alongside a boost of 27.99% for the period of the last 12 months. The shares increased approximately by -8.33% in the 7-day charts and went down by 55.34% in the period of the last 30 days. Common stock shares were driven by 26.40% during last recorded quarter.